Global Radioactive Iodine Ablation Therapy Market Growth (Status and Outlook) 2026-2032
The global Radioactive Iodine Ablation Therapy market size is predicted to grow from US$ 549 million in 2025 to US$ 793 million in 2032; it is expected to grow at a CAGR of 5.5% from 2026 to 2032.
Radioactive Iodine Ablation Therapy is a targeted internal radiotherapy that uses radioactive iodine-131 (I-131) to selectively destroy residual thyroid tissue or differentiated thyroid cancer cells. Leveraging the thyroid gland’s natural ability to concentrate iodine, the therapy delivers I-131 via oral or intravenous administration, enabling localized radiation deposition within the target tissue. It is widely applied in postoperative treatment of differentiated thyroid cancer, management of recurrent or metastatic lesions, and in selected cases of hyperthyroidism. Compared with surgery or external beam radiotherapy, radioactive iodine ablation offers high specificity, minimal invasiveness, and a standardized therapeutic workflow, making it a core modality in global nuclear medicine treatment pathways. With advances in nuclear medicine technologies, dosimetry, and isotope-supply systems, the therapy continues to serve as a crucial component in precision thyroid-disease management.The average gross profit margin of this product is 55%.
The demand for radioactive iodine ablation is rising as thyroid cancer screening improves and nuclear medicine infrastructure expands globally. Annual reports from pharmaceutical and nuclear-technology companies indicate sustained growth in differentiated thyroid cancer patients, along with increased clinical standardization of postoperative ablation therapy. Government investment in nuclear medicine departments, isotope-supply security, and radiopharmaceutical regulation provides strong industry support. Advances in radionuclide production, dosimetry, and formulation technologies continue to enhance precision and safety, strengthening clinical adoption.
Key challenges include the stability of isotope supply chains, stringent radiopharmaceutical regulations, and high compliance requirements for hospital nuclear facilities. Construction of nuclear medicine departments requires long cycles and significant investment, limiting adoption in some regions. Patient misconceptions regarding radiotherapy also necessitate continuous clinical education. Global supply-chain fluctuations may affect I-131 production and logistics, requiring robust inventory management. Emerging alternatives such as targeted therapies may introduce competitive pressure in select patient groups.
Demand is expanding across multiple medical tiers. Tertiary hospitals remain the primary users, prioritizing precision dosimetry and efficient treatment workflows. Regional medical centers are increasingly adopting nuclear-medicine capabilities, supported by government programs. Public information shows rising patient preference for personalized dosing, digital follow-up, and remote consultation, pushing institutions toward integrated treatment-management systems. The growth of multidisciplinary care pathways further strengthens collaborative diagnostic and therapeutic models.
Upstream components include I-131 isotope production, radiopharmaceutical formulation, lead-shielded transport devices, radiation measurement equipment, and nuclear-medicine consumables. National policies promoting nuclear-technology innovation and radiopharmaceutical localization enhance supply-chain security. Companies are improving formulation purity, protective packaging, and controlled-transport technology to ensure product quality. As regulatory systems mature, the upstream ecosystem is advancing toward higher standards, greater safety, and accelerated domestic substitution.
This Insight Report provides a comprehensive analysis of the global Radioactive Iodine Ablation Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Radioactive Iodine Ablation Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Radioactive Iodine Ablation Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radioactive Iodine Ablation Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radioactive Iodine Ablation Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Radioactive Iodine Ablation Therapy market by product type, application, key players and key regions and countries.
Radioactive Iodine Ablation Therapy is a targeted internal radiotherapy that uses radioactive iodine-131 (I-131) to selectively destroy residual thyroid tissue or differentiated thyroid cancer cells. Leveraging the thyroid gland’s natural ability to concentrate iodine, the therapy delivers I-131 via oral or intravenous administration, enabling localized radiation deposition within the target tissue. It is widely applied in postoperative treatment of differentiated thyroid cancer, management of recurrent or metastatic lesions, and in selected cases of hyperthyroidism. Compared with surgery or external beam radiotherapy, radioactive iodine ablation offers high specificity, minimal invasiveness, and a standardized therapeutic workflow, making it a core modality in global nuclear medicine treatment pathways. With advances in nuclear medicine technologies, dosimetry, and isotope-supply systems, the therapy continues to serve as a crucial component in precision thyroid-disease management.The average gross profit margin of this product is 55%.
The demand for radioactive iodine ablation is rising as thyroid cancer screening improves and nuclear medicine infrastructure expands globally. Annual reports from pharmaceutical and nuclear-technology companies indicate sustained growth in differentiated thyroid cancer patients, along with increased clinical standardization of postoperative ablation therapy. Government investment in nuclear medicine departments, isotope-supply security, and radiopharmaceutical regulation provides strong industry support. Advances in radionuclide production, dosimetry, and formulation technologies continue to enhance precision and safety, strengthening clinical adoption.
Key challenges include the stability of isotope supply chains, stringent radiopharmaceutical regulations, and high compliance requirements for hospital nuclear facilities. Construction of nuclear medicine departments requires long cycles and significant investment, limiting adoption in some regions. Patient misconceptions regarding radiotherapy also necessitate continuous clinical education. Global supply-chain fluctuations may affect I-131 production and logistics, requiring robust inventory management. Emerging alternatives such as targeted therapies may introduce competitive pressure in select patient groups.
Demand is expanding across multiple medical tiers. Tertiary hospitals remain the primary users, prioritizing precision dosimetry and efficient treatment workflows. Regional medical centers are increasingly adopting nuclear-medicine capabilities, supported by government programs. Public information shows rising patient preference for personalized dosing, digital follow-up, and remote consultation, pushing institutions toward integrated treatment-management systems. The growth of multidisciplinary care pathways further strengthens collaborative diagnostic and therapeutic models.
Upstream components include I-131 isotope production, radiopharmaceutical formulation, lead-shielded transport devices, radiation measurement equipment, and nuclear-medicine consumables. National policies promoting nuclear-technology innovation and radiopharmaceutical localization enhance supply-chain security. Companies are improving formulation purity, protective packaging, and controlled-transport technology to ensure product quality. As regulatory systems mature, the upstream ecosystem is advancing toward higher standards, greater safety, and accelerated domestic substitution.
Report Scope
LPI (LP Information)' newest research report, the “Radioactive Iodine Ablation Therapy Industry Forecast” looks at past sales and reviews total world Radioactive Iodine Ablation Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected Radioactive Iodine Ablation Therapy sales for 2026 through 2032. With Radioactive Iodine Ablation Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radioactive Iodine Ablation Therapy industry.This Insight Report provides a comprehensive analysis of the global Radioactive Iodine Ablation Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Radioactive Iodine Ablation Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Radioactive Iodine Ablation Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radioactive Iodine Ablation Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radioactive Iodine Ablation Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Radioactive Iodine Ablation Therapy market by product type, application, key players and key regions and countries.
Market Segmentation
Segmentation by Type:
- Gamma Radiation
- Beta Radiation
Segmentation by Care Setting:
- Outpatient RAI Therapy
- Inpatient RAI Therapy
Segmentation by Administration:
- Capsule Form
- Liquid Form
Segmentation by Application:
- Papillary Thyroid Cancer
- Follicular Thyroid Cancer
- Hurthle Cell Carcinoma
- Other
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Medtronic
- HealthTronics
- Galil Medical
- AngioDynamics
- Misonix
- SonaCare Medical
- Boston Scientific Corporation
- Neuwave Medical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radioactive Iodine Ablation Therapy Market Size (2021-2032)
2.1.2 Radioactive Iodine Ablation Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Radioactive Iodine Ablation Therapy by Country/Region (2021, 2025 & 2032)
2.2 Radioactive Iodine Ablation Therapy Segment by Type
2.2.1 Gamma Radiation
2.2.2 Beta Radiation
2.2.3 Radioactive Iodine Ablation Therapy Market Size by Type
2.2.3.1 Radioactive Iodine Ablation Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Radioactive Iodine Ablation Therapy Market Size Market Share by Type (2021-2026)
2.3 Radioactive Iodine Ablation Therapy Segment by Care Setting
2.3.1 Outpatient RAI Therapy
2.3.2 Inpatient RAI Therapy
2.3.3 Radioactive Iodine Ablation Therapy Market Size by Care Setting
2.3.3.1 Radioactive Iodine Ablation Therapy Market Size CAGR by Care Setting (2021 VS 2025 VS 2032)
2.3.3.2 Global Radioactive Iodine Ablation Therapy Market Size Market Share by Care Setting (2021-2026)
2.4 Radioactive Iodine Ablation Therapy Segment by Administration
2.4.1 Capsule Form
2.4.2 Liquid Form
2.4.3 Radioactive Iodine Ablation Therapy Market Size by Administration
2.4.3.1 Radioactive Iodine Ablation Therapy Market Size CAGR by Administration (2021 VS 2025 VS 2032)
2.4.3.2 Global Radioactive Iodine Ablation Therapy Market Size Market Share by Administration (2021-2026)
2.5 Radioactive Iodine Ablation Therapy Segment by Application
2.5.1 Papillary Thyroid Cancer
2.5.2 Follicular Thyroid Cancer
2.5.3 Hurthle Cell Carcinoma
2.5.4 Other
2.5.5 Radioactive Iodine Ablation Therapy Market Size by Application
2.5.5.1 Radioactive Iodine Ablation Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global Radioactive Iodine Ablation Therapy Market Size Market Share by Application (2021-2026)
3 RADIOACTIVE IODINE ABLATION THERAPY MARKET SIZE BY PLAYER
3.1 Radioactive Iodine Ablation Therapy Market Size Market Share by Player
3.1.1 Global Radioactive Iodine Ablation Therapy Revenue by Player (2021-2026)
3.1.2 Global Radioactive Iodine Ablation Therapy Revenue Market Share by Player (2021-2026)
3.2 Global Radioactive Iodine Ablation Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RADIOACTIVE IODINE ABLATION THERAPY BY REGION
4.1 Radioactive Iodine Ablation Therapy Market Size by Region (2021-2026)
4.2 Global Radioactive Iodine Ablation Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Radioactive Iodine Ablation Therapy Market Size Growth (2021-2026)
4.4 APAC Radioactive Iodine Ablation Therapy Market Size Growth (2021-2026)
4.5 Europe Radioactive Iodine Ablation Therapy Market Size Growth (2021-2026)
4.6 Middle East & Africa Radioactive Iodine Ablation Therapy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Radioactive Iodine Ablation Therapy Market Size by Country (2021-2026)
5.2 Americas Radioactive Iodine Ablation Therapy Market Size by Type (2021-2026)
5.3 Americas Radioactive Iodine Ablation Therapy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radioactive Iodine Ablation Therapy Market Size by Region (2021-2026)
6.2 APAC Radioactive Iodine Ablation Therapy Market Size by Type (2021-2026)
6.3 APAC Radioactive Iodine Ablation Therapy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Radioactive Iodine Ablation Therapy Market Size by Country (2021-2026)
7.2 Europe Radioactive Iodine Ablation Therapy Market Size by Type (2021-2026)
7.3 Europe Radioactive Iodine Ablation Therapy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radioactive Iodine Ablation Therapy by Region (2021-2026)
8.2 Middle East & Africa Radioactive Iodine Ablation Therapy Market Size by Type (2021-2026)
8.3 Middle East & Africa Radioactive Iodine Ablation Therapy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RADIOACTIVE IODINE ABLATION THERAPY MARKET FORECAST
10.1 Global Radioactive Iodine Ablation Therapy Forecast by Region (2027-2032)
10.1.1 Global Radioactive Iodine Ablation Therapy Forecast by Region (2027-2032)
10.1.2 Americas Radioactive Iodine Ablation Therapy Forecast
10.1.3 APAC Radioactive Iodine Ablation Therapy Forecast
10.1.4 Europe Radioactive Iodine Ablation Therapy Forecast
10.1.5 Middle East & Africa Radioactive Iodine Ablation Therapy Forecast
10.2 Americas Radioactive Iodine Ablation Therapy Forecast by Country (2027-2032)
10.2.1 United States Market Radioactive Iodine Ablation Therapy Forecast
10.2.2 Canada Market Radioactive Iodine Ablation Therapy Forecast
10.2.3 Mexico Market Radioactive Iodine Ablation Therapy Forecast
10.2.4 Brazil Market Radioactive Iodine Ablation Therapy Forecast
10.3 APAC Radioactive Iodine Ablation Therapy Forecast by Region (2027-2032)
10.3.1 China Radioactive Iodine Ablation Therapy Market Forecast
10.3.2 Japan Market Radioactive Iodine Ablation Therapy Forecast
10.3.3 Korea Market Radioactive Iodine Ablation Therapy Forecast
10.3.4 Southeast Asia Market Radioactive Iodine Ablation Therapy Forecast
10.3.5 India Market Radioactive Iodine Ablation Therapy Forecast
10.3.6 Australia Market Radioactive Iodine Ablation Therapy Forecast
10.4 Europe Radioactive Iodine Ablation Therapy Forecast by Country (2027-2032)
10.4.1 Germany Market Radioactive Iodine Ablation Therapy Forecast
10.4.2 France Market Radioactive Iodine Ablation Therapy Forecast
10.4.3 UK Market Radioactive Iodine Ablation Therapy Forecast
10.4.4 Italy Market Radioactive Iodine Ablation Therapy Forecast
10.4.5 Russia Market Radioactive Iodine Ablation Therapy Forecast
10.5 Middle East & Africa Radioactive Iodine Ablation Therapy Forecast by Region (2027-2032)
10.5.1 Egypt Market Radioactive Iodine Ablation Therapy Forecast
10.5.2 South Africa Market Radioactive Iodine Ablation Therapy Forecast
10.5.3 Israel Market Radioactive Iodine Ablation Therapy Forecast
10.5.4 Turkey Market Radioactive Iodine Ablation Therapy Forecast
10.6 Global Radioactive Iodine Ablation Therapy Forecast by Type (2027-2032)
10.7 Global Radioactive Iodine Ablation Therapy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Radioactive Iodine Ablation Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Medtronic
11.1.1 Medtronic Company Information
11.1.2 Medtronic Radioactive Iodine Ablation Therapy Product Offered
11.1.3 Medtronic Radioactive Iodine Ablation Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Medtronic Main Business Overview
11.1.5 Medtronic Latest Developments
11.2 HealthTronics
11.2.1 HealthTronics Company Information
11.2.2 HealthTronics Radioactive Iodine Ablation Therapy Product Offered
11.2.3 HealthTronics Radioactive Iodine Ablation Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 HealthTronics Main Business Overview
11.2.5 HealthTronics Latest Developments
11.3 Galil Medical
11.3.1 Galil Medical Company Information
11.3.2 Galil Medical Radioactive Iodine Ablation Therapy Product Offered
11.3.3 Galil Medical Radioactive Iodine Ablation Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Galil Medical Main Business Overview
11.3.5 Galil Medical Latest Developments
11.4 AngioDynamics
11.4.1 AngioDynamics Company Information
11.4.2 AngioDynamics Radioactive Iodine Ablation Therapy Product Offered
11.4.3 AngioDynamics Radioactive Iodine Ablation Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 AngioDynamics Main Business Overview
11.4.5 AngioDynamics Latest Developments
11.5 Misonix
11.5.1 Misonix Company Information
11.5.2 Misonix Radioactive Iodine Ablation Therapy Product Offered
11.5.3 Misonix Radioactive Iodine Ablation Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Misonix Main Business Overview
11.5.5 Misonix Latest Developments
11.6 SonaCare Medical
11.6.1 SonaCare Medical Company Information
11.6.2 SonaCare Medical Radioactive Iodine Ablation Therapy Product Offered
11.6.3 SonaCare Medical Radioactive Iodine Ablation Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 SonaCare Medical Main Business Overview
11.6.5 SonaCare Medical Latest Developments
11.7 Boston Scientific Corporation
11.7.1 Boston Scientific Corporation Company Information
11.7.2 Boston Scientific Corporation Radioactive Iodine Ablation Therapy Product Offered
11.7.3 Boston Scientific Corporation Radioactive Iodine Ablation Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Boston Scientific Corporation Main Business Overview
11.7.5 Boston Scientific Corporation Latest Developments
11.8 Neuwave Medical
11.8.1 Neuwave Medical Company Information
11.8.2 Neuwave Medical Radioactive Iodine Ablation Therapy Product Offered
11.8.3 Neuwave Medical Radioactive Iodine Ablation Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Neuwave Medical Main Business Overview
11.8.5 Neuwave Medical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radioactive Iodine Ablation Therapy Market Size (2021-2032)
2.1.2 Radioactive Iodine Ablation Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Radioactive Iodine Ablation Therapy by Country/Region (2021, 2025 & 2032)
2.2 Radioactive Iodine Ablation Therapy Segment by Type
2.2.1 Gamma Radiation
2.2.2 Beta Radiation
2.2.3 Radioactive Iodine Ablation Therapy Market Size by Type
2.2.3.1 Radioactive Iodine Ablation Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Radioactive Iodine Ablation Therapy Market Size Market Share by Type (2021-2026)
2.3 Radioactive Iodine Ablation Therapy Segment by Care Setting
2.3.1 Outpatient RAI Therapy
2.3.2 Inpatient RAI Therapy
2.3.3 Radioactive Iodine Ablation Therapy Market Size by Care Setting
2.3.3.1 Radioactive Iodine Ablation Therapy Market Size CAGR by Care Setting (2021 VS 2025 VS 2032)
2.3.3.2 Global Radioactive Iodine Ablation Therapy Market Size Market Share by Care Setting (2021-2026)
2.4 Radioactive Iodine Ablation Therapy Segment by Administration
2.4.1 Capsule Form
2.4.2 Liquid Form
2.4.3 Radioactive Iodine Ablation Therapy Market Size by Administration
2.4.3.1 Radioactive Iodine Ablation Therapy Market Size CAGR by Administration (2021 VS 2025 VS 2032)
2.4.3.2 Global Radioactive Iodine Ablation Therapy Market Size Market Share by Administration (2021-2026)
2.5 Radioactive Iodine Ablation Therapy Segment by Application
2.5.1 Papillary Thyroid Cancer
2.5.2 Follicular Thyroid Cancer
2.5.3 Hurthle Cell Carcinoma
2.5.4 Other
2.5.5 Radioactive Iodine Ablation Therapy Market Size by Application
2.5.5.1 Radioactive Iodine Ablation Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global Radioactive Iodine Ablation Therapy Market Size Market Share by Application (2021-2026)
3 RADIOACTIVE IODINE ABLATION THERAPY MARKET SIZE BY PLAYER
3.1 Radioactive Iodine Ablation Therapy Market Size Market Share by Player
3.1.1 Global Radioactive Iodine Ablation Therapy Revenue by Player (2021-2026)
3.1.2 Global Radioactive Iodine Ablation Therapy Revenue Market Share by Player (2021-2026)
3.2 Global Radioactive Iodine Ablation Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RADIOACTIVE IODINE ABLATION THERAPY BY REGION
4.1 Radioactive Iodine Ablation Therapy Market Size by Region (2021-2026)
4.2 Global Radioactive Iodine Ablation Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Radioactive Iodine Ablation Therapy Market Size Growth (2021-2026)
4.4 APAC Radioactive Iodine Ablation Therapy Market Size Growth (2021-2026)
4.5 Europe Radioactive Iodine Ablation Therapy Market Size Growth (2021-2026)
4.6 Middle East & Africa Radioactive Iodine Ablation Therapy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Radioactive Iodine Ablation Therapy Market Size by Country (2021-2026)
5.2 Americas Radioactive Iodine Ablation Therapy Market Size by Type (2021-2026)
5.3 Americas Radioactive Iodine Ablation Therapy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radioactive Iodine Ablation Therapy Market Size by Region (2021-2026)
6.2 APAC Radioactive Iodine Ablation Therapy Market Size by Type (2021-2026)
6.3 APAC Radioactive Iodine Ablation Therapy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Radioactive Iodine Ablation Therapy Market Size by Country (2021-2026)
7.2 Europe Radioactive Iodine Ablation Therapy Market Size by Type (2021-2026)
7.3 Europe Radioactive Iodine Ablation Therapy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radioactive Iodine Ablation Therapy by Region (2021-2026)
8.2 Middle East & Africa Radioactive Iodine Ablation Therapy Market Size by Type (2021-2026)
8.3 Middle East & Africa Radioactive Iodine Ablation Therapy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RADIOACTIVE IODINE ABLATION THERAPY MARKET FORECAST
10.1 Global Radioactive Iodine Ablation Therapy Forecast by Region (2027-2032)
10.1.1 Global Radioactive Iodine Ablation Therapy Forecast by Region (2027-2032)
10.1.2 Americas Radioactive Iodine Ablation Therapy Forecast
10.1.3 APAC Radioactive Iodine Ablation Therapy Forecast
10.1.4 Europe Radioactive Iodine Ablation Therapy Forecast
10.1.5 Middle East & Africa Radioactive Iodine Ablation Therapy Forecast
10.2 Americas Radioactive Iodine Ablation Therapy Forecast by Country (2027-2032)
10.2.1 United States Market Radioactive Iodine Ablation Therapy Forecast
10.2.2 Canada Market Radioactive Iodine Ablation Therapy Forecast
10.2.3 Mexico Market Radioactive Iodine Ablation Therapy Forecast
10.2.4 Brazil Market Radioactive Iodine Ablation Therapy Forecast
10.3 APAC Radioactive Iodine Ablation Therapy Forecast by Region (2027-2032)
10.3.1 China Radioactive Iodine Ablation Therapy Market Forecast
10.3.2 Japan Market Radioactive Iodine Ablation Therapy Forecast
10.3.3 Korea Market Radioactive Iodine Ablation Therapy Forecast
10.3.4 Southeast Asia Market Radioactive Iodine Ablation Therapy Forecast
10.3.5 India Market Radioactive Iodine Ablation Therapy Forecast
10.3.6 Australia Market Radioactive Iodine Ablation Therapy Forecast
10.4 Europe Radioactive Iodine Ablation Therapy Forecast by Country (2027-2032)
10.4.1 Germany Market Radioactive Iodine Ablation Therapy Forecast
10.4.2 France Market Radioactive Iodine Ablation Therapy Forecast
10.4.3 UK Market Radioactive Iodine Ablation Therapy Forecast
10.4.4 Italy Market Radioactive Iodine Ablation Therapy Forecast
10.4.5 Russia Market Radioactive Iodine Ablation Therapy Forecast
10.5 Middle East & Africa Radioactive Iodine Ablation Therapy Forecast by Region (2027-2032)
10.5.1 Egypt Market Radioactive Iodine Ablation Therapy Forecast
10.5.2 South Africa Market Radioactive Iodine Ablation Therapy Forecast
10.5.3 Israel Market Radioactive Iodine Ablation Therapy Forecast
10.5.4 Turkey Market Radioactive Iodine Ablation Therapy Forecast
10.6 Global Radioactive Iodine Ablation Therapy Forecast by Type (2027-2032)
10.7 Global Radioactive Iodine Ablation Therapy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Radioactive Iodine Ablation Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Medtronic
11.1.1 Medtronic Company Information
11.1.2 Medtronic Radioactive Iodine Ablation Therapy Product Offered
11.1.3 Medtronic Radioactive Iodine Ablation Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Medtronic Main Business Overview
11.1.5 Medtronic Latest Developments
11.2 HealthTronics
11.2.1 HealthTronics Company Information
11.2.2 HealthTronics Radioactive Iodine Ablation Therapy Product Offered
11.2.3 HealthTronics Radioactive Iodine Ablation Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 HealthTronics Main Business Overview
11.2.5 HealthTronics Latest Developments
11.3 Galil Medical
11.3.1 Galil Medical Company Information
11.3.2 Galil Medical Radioactive Iodine Ablation Therapy Product Offered
11.3.3 Galil Medical Radioactive Iodine Ablation Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Galil Medical Main Business Overview
11.3.5 Galil Medical Latest Developments
11.4 AngioDynamics
11.4.1 AngioDynamics Company Information
11.4.2 AngioDynamics Radioactive Iodine Ablation Therapy Product Offered
11.4.3 AngioDynamics Radioactive Iodine Ablation Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 AngioDynamics Main Business Overview
11.4.5 AngioDynamics Latest Developments
11.5 Misonix
11.5.1 Misonix Company Information
11.5.2 Misonix Radioactive Iodine Ablation Therapy Product Offered
11.5.3 Misonix Radioactive Iodine Ablation Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Misonix Main Business Overview
11.5.5 Misonix Latest Developments
11.6 SonaCare Medical
11.6.1 SonaCare Medical Company Information
11.6.2 SonaCare Medical Radioactive Iodine Ablation Therapy Product Offered
11.6.3 SonaCare Medical Radioactive Iodine Ablation Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 SonaCare Medical Main Business Overview
11.6.5 SonaCare Medical Latest Developments
11.7 Boston Scientific Corporation
11.7.1 Boston Scientific Corporation Company Information
11.7.2 Boston Scientific Corporation Radioactive Iodine Ablation Therapy Product Offered
11.7.3 Boston Scientific Corporation Radioactive Iodine Ablation Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Boston Scientific Corporation Main Business Overview
11.7.5 Boston Scientific Corporation Latest Developments
11.8 Neuwave Medical
11.8.1 Neuwave Medical Company Information
11.8.2 Neuwave Medical Radioactive Iodine Ablation Therapy Product Offered
11.8.3 Neuwave Medical Radioactive Iodine Ablation Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Neuwave Medical Main Business Overview
11.8.5 Neuwave Medical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Radioactive Iodine Ablation Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Radioactive Iodine Ablation Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Gamma Radiation
Table 4. Major Players of Beta Radiation
Table 5. Radioactive Iodine Ablation Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Radioactive Iodine Ablation Therapy Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Radioactive Iodine Ablation Therapy Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Outpatient RAI Therapy
Table 9. Major Players of Inpatient RAI Therapy
Table 10. Radioactive Iodine Ablation Therapy Market Size CAGR by Care Setting (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Radioactive Iodine Ablation Therapy Market Size by Care Setting (2021-2026) & ($ millions)
Table 12. Global Radioactive Iodine Ablation Therapy Market Size Market Share by Care Setting (2021-2026)
Table 13. Major Players of Capsule Form
Table 14. Major Players of Liquid Form
Table 15. Radioactive Iodine Ablation Therapy Market Size CAGR by Administration (2021 VS 2025 VS 2032) & ($ millions)
Table 16. Global Radioactive Iodine Ablation Therapy Market Size by Administration (2021-2026) & ($ millions)
Table 17. Global Radioactive Iodine Ablation Therapy Market Size Market Share by Administration (2021-2026)
Table 18. Radioactive Iodine Ablation Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Radioactive Iodine Ablation Therapy Market Size by Application (2021-2026) & ($ millions)
Table 20. Global Radioactive Iodine Ablation Therapy Market Size Market Share by Application (2021-2026)
Table 21. Global Radioactive Iodine Ablation Therapy Revenue by Player (2021-2026) & ($ millions)
Table 22. Global Radioactive Iodine Ablation Therapy Revenue Market Share by Player (2021-2026)
Table 23. Radioactive Iodine Ablation Therapy Key Players Head office and Products Offered
Table 24. Radioactive Iodine Ablation Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Radioactive Iodine Ablation Therapy Market Size by Region (2021-2026) & ($ millions)
Table 28. Global Radioactive Iodine Ablation Therapy Market Size Market Share by Region (2021-2026)
Table 29. Global Radioactive Iodine Ablation Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 30. Global Radioactive Iodine Ablation Therapy Revenue Market Share by Country/Region (2021-2026)
Table 31. Americas Radioactive Iodine Ablation Therapy Market Size by Country (2021-2026) & ($ millions)
Table 32. Americas Radioactive Iodine Ablation Therapy Market Size Market Share by Country (2021-2026)
Table 33. Americas Radioactive Iodine Ablation Therapy Market Size by Type (2021-2026) & ($ millions)
Table 34. Americas Radioactive Iodine Ablation Therapy Market Size Market Share by Type (2021-2026)
Table 35. Americas Radioactive Iodine Ablation Therapy Market Size by Application (2021-2026) & ($ millions)
Table 36. Americas Radioactive Iodine Ablation Therapy Market Size Market Share by Application (2021-2026)
Table 37. APAC Radioactive Iodine Ablation Therapy Market Size by Region (2021-2026) & ($ millions)
Table 38. APAC Radioactive Iodine Ablation Therapy Market Size Market Share by Region (2021-2026)
Table 39. APAC Radioactive Iodine Ablation Therapy Market Size by Type (2021-2026) & ($ millions)
Table 40. APAC Radioactive Iodine Ablation Therapy Market Size by Application (2021-2026) & ($ millions)
Table 41. Europe Radioactive Iodine Ablation Therapy Market Size by Country (2021-2026) & ($ millions)
Table 42. Europe Radioactive Iodine Ablation Therapy Market Size Market Share by Country (2021-2026)
Table 43. Europe Radioactive Iodine Ablation Therapy Market Size by Type (2021-2026) & ($ millions)
Table 44. Europe Radioactive Iodine Ablation Therapy Market Size by Application (2021-2026) & ($ millions)
Table 45. Middle East & Africa Radioactive Iodine Ablation Therapy Market Size by Region (2021-2026) & ($ millions)
Table 46. Middle East & Africa Radioactive Iodine Ablation Therapy Market Size by Type (2021-2026) & ($ millions)
Table 47. Middle East & Africa Radioactive Iodine Ablation Therapy Market Size by Application (2021-2026) & ($ millions)
Table 48. Key Market Drivers & Growth Opportunities of Radioactive Iodine Ablation Therapy
Table 49. Key Market Challenges & Risks of Radioactive Iodine Ablation Therapy
Table 50. Key Industry Trends of Radioactive Iodine Ablation Therapy
Table 51. Global Radioactive Iodine Ablation Therapy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 52. Global Radioactive Iodine Ablation Therapy Market Size Market Share Forecast by Region (2027-2032)
Table 53. Global Radioactive Iodine Ablation Therapy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 54. Global Radioactive Iodine Ablation Therapy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 55. Medtronic Details, Company Type, Radioactive Iodine Ablation Therapy Area Served and Its Competitors
Table 56. Medtronic Radioactive Iodine Ablation Therapy Product Offered
Table 57. Medtronic Radioactive Iodine Ablation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Medtronic Main Business
Table 59. Medtronic Latest Developments
Table 60. HealthTronics Details, Company Type, Radioactive Iodine Ablation Therapy Area Served and Its Competitors
Table 61. HealthTronics Radioactive Iodine Ablation Therapy Product Offered
Table 62. HealthTronics Radioactive Iodine Ablation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. HealthTronics Main Business
Table 64. HealthTronics Latest Developments
Table 65. Galil Medical Details, Company Type, Radioactive Iodine Ablation Therapy Area Served and Its Competitors
Table 66. Galil Medical Radioactive Iodine Ablation Therapy Product Offered
Table 67. Galil Medical Radioactive Iodine Ablation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Galil Medical Main Business
Table 69. Galil Medical Latest Developments
Table 70. AngioDynamics Details, Company Type, Radioactive Iodine Ablation Therapy Area Served and Its Competitors
Table 71. AngioDynamics Radioactive Iodine Ablation Therapy Product Offered
Table 72. AngioDynamics Radioactive Iodine Ablation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. AngioDynamics Main Business
Table 74. AngioDynamics Latest Developments
Table 75. Misonix Details, Company Type, Radioactive Iodine Ablation Therapy Area Served and Its Competitors
Table 76. Misonix Radioactive Iodine Ablation Therapy Product Offered
Table 77. Misonix Radioactive Iodine Ablation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Misonix Main Business
Table 79. Misonix Latest Developments
Table 80. SonaCare Medical Details, Company Type, Radioactive Iodine Ablation Therapy Area Served and Its Competitors
Table 81. SonaCare Medical Radioactive Iodine Ablation Therapy Product Offered
Table 82. SonaCare Medical Radioactive Iodine Ablation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. SonaCare Medical Main Business
Table 84. SonaCare Medical Latest Developments
Table 85. Boston Scientific Corporation Details, Company Type, Radioactive Iodine Ablation Therapy Area Served and Its Competitors
Table 86. Boston Scientific Corporation Radioactive Iodine Ablation Therapy Product Offered
Table 87. Boston Scientific Corporation Radioactive Iodine Ablation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Boston Scientific Corporation Main Business
Table 89. Boston Scientific Corporation Latest Developments
Table 90. Neuwave Medical Details, Company Type, Radioactive Iodine Ablation Therapy Area Served and Its Competitors
Table 91. Neuwave Medical Radioactive Iodine Ablation Therapy Product Offered
Table 92. Neuwave Medical Radioactive Iodine Ablation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Neuwave Medical Main Business
Table 94. Neuwave Medical Latest Developments
Table 1. Radioactive Iodine Ablation Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Radioactive Iodine Ablation Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Gamma Radiation
Table 4. Major Players of Beta Radiation
Table 5. Radioactive Iodine Ablation Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Radioactive Iodine Ablation Therapy Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Radioactive Iodine Ablation Therapy Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Outpatient RAI Therapy
Table 9. Major Players of Inpatient RAI Therapy
Table 10. Radioactive Iodine Ablation Therapy Market Size CAGR by Care Setting (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Radioactive Iodine Ablation Therapy Market Size by Care Setting (2021-2026) & ($ millions)
Table 12. Global Radioactive Iodine Ablation Therapy Market Size Market Share by Care Setting (2021-2026)
Table 13. Major Players of Capsule Form
Table 14. Major Players of Liquid Form
Table 15. Radioactive Iodine Ablation Therapy Market Size CAGR by Administration (2021 VS 2025 VS 2032) & ($ millions)
Table 16. Global Radioactive Iodine Ablation Therapy Market Size by Administration (2021-2026) & ($ millions)
Table 17. Global Radioactive Iodine Ablation Therapy Market Size Market Share by Administration (2021-2026)
Table 18. Radioactive Iodine Ablation Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Radioactive Iodine Ablation Therapy Market Size by Application (2021-2026) & ($ millions)
Table 20. Global Radioactive Iodine Ablation Therapy Market Size Market Share by Application (2021-2026)
Table 21. Global Radioactive Iodine Ablation Therapy Revenue by Player (2021-2026) & ($ millions)
Table 22. Global Radioactive Iodine Ablation Therapy Revenue Market Share by Player (2021-2026)
Table 23. Radioactive Iodine Ablation Therapy Key Players Head office and Products Offered
Table 24. Radioactive Iodine Ablation Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Radioactive Iodine Ablation Therapy Market Size by Region (2021-2026) & ($ millions)
Table 28. Global Radioactive Iodine Ablation Therapy Market Size Market Share by Region (2021-2026)
Table 29. Global Radioactive Iodine Ablation Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 30. Global Radioactive Iodine Ablation Therapy Revenue Market Share by Country/Region (2021-2026)
Table 31. Americas Radioactive Iodine Ablation Therapy Market Size by Country (2021-2026) & ($ millions)
Table 32. Americas Radioactive Iodine Ablation Therapy Market Size Market Share by Country (2021-2026)
Table 33. Americas Radioactive Iodine Ablation Therapy Market Size by Type (2021-2026) & ($ millions)
Table 34. Americas Radioactive Iodine Ablation Therapy Market Size Market Share by Type (2021-2026)
Table 35. Americas Radioactive Iodine Ablation Therapy Market Size by Application (2021-2026) & ($ millions)
Table 36. Americas Radioactive Iodine Ablation Therapy Market Size Market Share by Application (2021-2026)
Table 37. APAC Radioactive Iodine Ablation Therapy Market Size by Region (2021-2026) & ($ millions)
Table 38. APAC Radioactive Iodine Ablation Therapy Market Size Market Share by Region (2021-2026)
Table 39. APAC Radioactive Iodine Ablation Therapy Market Size by Type (2021-2026) & ($ millions)
Table 40. APAC Radioactive Iodine Ablation Therapy Market Size by Application (2021-2026) & ($ millions)
Table 41. Europe Radioactive Iodine Ablation Therapy Market Size by Country (2021-2026) & ($ millions)
Table 42. Europe Radioactive Iodine Ablation Therapy Market Size Market Share by Country (2021-2026)
Table 43. Europe Radioactive Iodine Ablation Therapy Market Size by Type (2021-2026) & ($ millions)
Table 44. Europe Radioactive Iodine Ablation Therapy Market Size by Application (2021-2026) & ($ millions)
Table 45. Middle East & Africa Radioactive Iodine Ablation Therapy Market Size by Region (2021-2026) & ($ millions)
Table 46. Middle East & Africa Radioactive Iodine Ablation Therapy Market Size by Type (2021-2026) & ($ millions)
Table 47. Middle East & Africa Radioactive Iodine Ablation Therapy Market Size by Application (2021-2026) & ($ millions)
Table 48. Key Market Drivers & Growth Opportunities of Radioactive Iodine Ablation Therapy
Table 49. Key Market Challenges & Risks of Radioactive Iodine Ablation Therapy
Table 50. Key Industry Trends of Radioactive Iodine Ablation Therapy
Table 51. Global Radioactive Iodine Ablation Therapy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 52. Global Radioactive Iodine Ablation Therapy Market Size Market Share Forecast by Region (2027-2032)
Table 53. Global Radioactive Iodine Ablation Therapy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 54. Global Radioactive Iodine Ablation Therapy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 55. Medtronic Details, Company Type, Radioactive Iodine Ablation Therapy Area Served and Its Competitors
Table 56. Medtronic Radioactive Iodine Ablation Therapy Product Offered
Table 57. Medtronic Radioactive Iodine Ablation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Medtronic Main Business
Table 59. Medtronic Latest Developments
Table 60. HealthTronics Details, Company Type, Radioactive Iodine Ablation Therapy Area Served and Its Competitors
Table 61. HealthTronics Radioactive Iodine Ablation Therapy Product Offered
Table 62. HealthTronics Radioactive Iodine Ablation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. HealthTronics Main Business
Table 64. HealthTronics Latest Developments
Table 65. Galil Medical Details, Company Type, Radioactive Iodine Ablation Therapy Area Served and Its Competitors
Table 66. Galil Medical Radioactive Iodine Ablation Therapy Product Offered
Table 67. Galil Medical Radioactive Iodine Ablation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Galil Medical Main Business
Table 69. Galil Medical Latest Developments
Table 70. AngioDynamics Details, Company Type, Radioactive Iodine Ablation Therapy Area Served and Its Competitors
Table 71. AngioDynamics Radioactive Iodine Ablation Therapy Product Offered
Table 72. AngioDynamics Radioactive Iodine Ablation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. AngioDynamics Main Business
Table 74. AngioDynamics Latest Developments
Table 75. Misonix Details, Company Type, Radioactive Iodine Ablation Therapy Area Served and Its Competitors
Table 76. Misonix Radioactive Iodine Ablation Therapy Product Offered
Table 77. Misonix Radioactive Iodine Ablation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Misonix Main Business
Table 79. Misonix Latest Developments
Table 80. SonaCare Medical Details, Company Type, Radioactive Iodine Ablation Therapy Area Served and Its Competitors
Table 81. SonaCare Medical Radioactive Iodine Ablation Therapy Product Offered
Table 82. SonaCare Medical Radioactive Iodine Ablation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. SonaCare Medical Main Business
Table 84. SonaCare Medical Latest Developments
Table 85. Boston Scientific Corporation Details, Company Type, Radioactive Iodine Ablation Therapy Area Served and Its Competitors
Table 86. Boston Scientific Corporation Radioactive Iodine Ablation Therapy Product Offered
Table 87. Boston Scientific Corporation Radioactive Iodine Ablation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Boston Scientific Corporation Main Business
Table 89. Boston Scientific Corporation Latest Developments
Table 90. Neuwave Medical Details, Company Type, Radioactive Iodine Ablation Therapy Area Served and Its Competitors
Table 91. Neuwave Medical Radioactive Iodine Ablation Therapy Product Offered
Table 92. Neuwave Medical Radioactive Iodine Ablation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Neuwave Medical Main Business
Table 94. Neuwave Medical Latest Developments
LIST OF FIGURES
Figure 1. Radioactive Iodine Ablation Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Radioactive Iodine Ablation Therapy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Radioactive Iodine Ablation Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Radioactive Iodine Ablation Therapy Sales Market Share by Country/Region (2025)
Figure 8. Radioactive Iodine Ablation Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Radioactive Iodine Ablation Therapy Market Size Market Share by Type in 2025
Figure 10. Global Radioactive Iodine Ablation Therapy Market Size Market Share by Care Setting in 2025
Figure 11. Global Radioactive Iodine Ablation Therapy Market Size Market Share by Administration in 2025
Figure 12. Radioactive Iodine Ablation Therapy in Papillary Thyroid Cancer
Figure 13. Global Radioactive Iodine Ablation Therapy Market: Papillary Thyroid Cancer (2021-2026) & ($ millions)
Figure 14. Radioactive Iodine Ablation Therapy in Follicular Thyroid Cancer
Figure 15. Global Radioactive Iodine Ablation Therapy Market: Follicular Thyroid Cancer (2021-2026) & ($ millions)
Figure 16. Radioactive Iodine Ablation Therapy in Hurthle Cell Carcinoma
Figure 17. Global Radioactive Iodine Ablation Therapy Market: Hurthle Cell Carcinoma (2021-2026) & ($ millions)
Figure 18. Radioactive Iodine Ablation Therapy in Other
Figure 19. Global Radioactive Iodine Ablation Therapy Market: Other (2021-2026) & ($ millions)
Figure 20. Global Radioactive Iodine Ablation Therapy Market Size Market Share by Application in 2025
Figure 21. Global Radioactive Iodine Ablation Therapy Revenue Market Share by Player in 2025
Figure 22. Global Radioactive Iodine Ablation Therapy Market Size Market Share by Region (2021-2026)
Figure 23. Americas Radioactive Iodine Ablation Therapy Market Size 2021-2026 ($ millions)
Figure 24. APAC Radioactive Iodine Ablation Therapy Market Size 2021-2026 ($ millions)
Figure 25. Europe Radioactive Iodine Ablation Therapy Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Radioactive Iodine Ablation Therapy Market Size 2021-2026 ($ millions)
Figure 27. Americas Radioactive Iodine Ablation Therapy Value Market Share by Country in 2025
Figure 28. United States Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Radioactive Iodine Ablation Therapy Market Size Market Share by Region in 2025
Figure 33. APAC Radioactive Iodine Ablation Therapy Market Size Market Share by Type (2021-2026)
Figure 34. APAC Radioactive Iodine Ablation Therapy Market Size Market Share by Application (2021-2026)
Figure 35. China Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 39. India Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Radioactive Iodine Ablation Therapy Market Size Market Share by Country in 2025
Figure 42. Europe Radioactive Iodine Ablation Therapy Market Size Market Share by Type (2021-2026)
Figure 43. Europe Radioactive Iodine Ablation Therapy Market Size Market Share by Application (2021-2026)
Figure 44. Germany Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 45. France Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Radioactive Iodine Ablation Therapy Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Radioactive Iodine Ablation Therapy Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Radioactive Iodine Ablation Therapy Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 58. APAC Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 59. Europe Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 61. United States Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 62. Canada Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 63. Mexico Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 64. Brazil Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 65. China Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 66. Japan Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 67. Korea Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 69. India Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 70. Australia Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 71. Germany Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 72. France Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 73. UK Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 74. Italy Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 75. Russia Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 76. Egypt Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 77. South Africa Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 78. Israel Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 79. Turkey Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 80. Global Radioactive Iodine Ablation Therapy Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Radioactive Iodine Ablation Therapy Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 1. Radioactive Iodine Ablation Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Radioactive Iodine Ablation Therapy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Radioactive Iodine Ablation Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Radioactive Iodine Ablation Therapy Sales Market Share by Country/Region (2025)
Figure 8. Radioactive Iodine Ablation Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Radioactive Iodine Ablation Therapy Market Size Market Share by Type in 2025
Figure 10. Global Radioactive Iodine Ablation Therapy Market Size Market Share by Care Setting in 2025
Figure 11. Global Radioactive Iodine Ablation Therapy Market Size Market Share by Administration in 2025
Figure 12. Radioactive Iodine Ablation Therapy in Papillary Thyroid Cancer
Figure 13. Global Radioactive Iodine Ablation Therapy Market: Papillary Thyroid Cancer (2021-2026) & ($ millions)
Figure 14. Radioactive Iodine Ablation Therapy in Follicular Thyroid Cancer
Figure 15. Global Radioactive Iodine Ablation Therapy Market: Follicular Thyroid Cancer (2021-2026) & ($ millions)
Figure 16. Radioactive Iodine Ablation Therapy in Hurthle Cell Carcinoma
Figure 17. Global Radioactive Iodine Ablation Therapy Market: Hurthle Cell Carcinoma (2021-2026) & ($ millions)
Figure 18. Radioactive Iodine Ablation Therapy in Other
Figure 19. Global Radioactive Iodine Ablation Therapy Market: Other (2021-2026) & ($ millions)
Figure 20. Global Radioactive Iodine Ablation Therapy Market Size Market Share by Application in 2025
Figure 21. Global Radioactive Iodine Ablation Therapy Revenue Market Share by Player in 2025
Figure 22. Global Radioactive Iodine Ablation Therapy Market Size Market Share by Region (2021-2026)
Figure 23. Americas Radioactive Iodine Ablation Therapy Market Size 2021-2026 ($ millions)
Figure 24. APAC Radioactive Iodine Ablation Therapy Market Size 2021-2026 ($ millions)
Figure 25. Europe Radioactive Iodine Ablation Therapy Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Radioactive Iodine Ablation Therapy Market Size 2021-2026 ($ millions)
Figure 27. Americas Radioactive Iodine Ablation Therapy Value Market Share by Country in 2025
Figure 28. United States Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Radioactive Iodine Ablation Therapy Market Size Market Share by Region in 2025
Figure 33. APAC Radioactive Iodine Ablation Therapy Market Size Market Share by Type (2021-2026)
Figure 34. APAC Radioactive Iodine Ablation Therapy Market Size Market Share by Application (2021-2026)
Figure 35. China Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 39. India Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Radioactive Iodine Ablation Therapy Market Size Market Share by Country in 2025
Figure 42. Europe Radioactive Iodine Ablation Therapy Market Size Market Share by Type (2021-2026)
Figure 43. Europe Radioactive Iodine Ablation Therapy Market Size Market Share by Application (2021-2026)
Figure 44. Germany Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 45. France Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Radioactive Iodine Ablation Therapy Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Radioactive Iodine Ablation Therapy Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Radioactive Iodine Ablation Therapy Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Radioactive Iodine Ablation Therapy Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 58. APAC Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 59. Europe Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 61. United States Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 62. Canada Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 63. Mexico Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 64. Brazil Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 65. China Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 66. Japan Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 67. Korea Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 69. India Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 70. Australia Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 71. Germany Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 72. France Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 73. UK Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 74. Italy Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 75. Russia Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 76. Egypt Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 77. South Africa Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 78. Israel Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 79. Turkey Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
Figure 80. Global Radioactive Iodine Ablation Therapy Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Radioactive Iodine Ablation Therapy Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Radioactive Iodine Ablation Therapy Market Size 2027-2032 ($ millions)
